Beverly Hills man gets 30 years for fentanyl scheme

A Beverly Hills man who made millions of dollars in crypto-currency by manufacturing and selling online a powerful synthetic opioid similar to fentanyl was sentenced Wednesday to 30 years in federal prison.

Andrew Tablack, 30, was convicted in July of one count of manufacturing, distributing, and possessing with intent to manufacture and distribute pills containing cyclopropyl fentanyl — an analogue of fentanyl — and one count of conspiracy, according to the U.S. Attorney’s Office for the District of New Jersey.

From at least March through December 2017, Tablack ran the pill-making operation that distributed millions of fentanyl analogue pills throughout the United States.

Tablack manufactured the pills in clandestine labs in and near Los Angeles and sold them anonymously on the dark web, the internet’s black market, using the moniker “XanaxKing2.”

He shipped about 400,000 of the illegal pills per month and made millions of dollars from his illegal operation in digital currency that is commonly used in the black market due to its relative anonymity.

In addition to the prison term, Tablack was sentenced to three years of supervised release and ordered to forfeit various crypto-currency holdings and electronic devices.

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Skip to content
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Essential Cookies

Essential Cookies should be enabled at all times so that we can save your preferences for cookie settings.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.